GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (OTCPK:NXSCF) » Definitions » Short-Term Debt

NXSCF (Next Science) Short-Term Debt : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Next Science Short-Term Debt?

Next Science's Short-Term Debt for the quarter that ended in Dec. 2024 was $0.00 Mil.

Next Science's quarterly Short-Term Debt increased from Dec. 2023 ($0.00 Mil) to Jun. 2024 ($0.26 Mil) but then declined from Jun. 2024 ($0.26 Mil) to Dec. 2024 ($0.00 Mil).

Next Science Short-Term Debt Historical Data

The historical data trend for Next Science's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Short-Term Debt Chart

Next Science Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial - - - - -

Next Science Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.27 - 0.26 -

Next Science Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Next Science Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Next Science's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (OTCPK:NXSCF) » Definitions » Short-Term Debt
Comparable Companies
ASX:LGP ASX:ECS ASX:IDT ASX:CAN ASX:PER ASX:AGH ASX:RGT ASX:EOF ASX:IVX ASX:EXL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
NXS:Australia
Address
264-278 George Street, Level 14, Australia Square, HWL Ebsworth, Sydney, NSW, AUS, 2000
Website
https://www.nextscience.com
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.